DE68918285D1 - Methode für behandlung von transplantaten vor transplantationen. - Google Patents
Methode für behandlung von transplantaten vor transplantationen.Info
- Publication number
- DE68918285D1 DE68918285D1 DE68918285T DE68918285T DE68918285D1 DE 68918285 D1 DE68918285 D1 DE 68918285D1 DE 68918285 T DE68918285 T DE 68918285T DE 68918285 T DE68918285 T DE 68918285T DE 68918285 D1 DE68918285 D1 DE 68918285D1
- Authority
- DE
- Germany
- Prior art keywords
- transplants
- grafts
- treating
- host
- perfused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/258,276 US5135915A (en) | 1988-10-14 | 1988-10-14 | Method for the treatment of grafts prior to transplantation using TGF-.beta. |
PCT/US1989/004429 WO1990003812A1 (en) | 1988-10-14 | 1989-10-10 | Method for the treatment of grafts prior to transplantation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68918285D1 true DE68918285D1 (de) | 1994-10-20 |
DE68918285T2 DE68918285T2 (de) | 1995-03-02 |
Family
ID=22979869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68918285T Expired - Lifetime DE68918285T2 (de) | 1988-10-14 | 1989-10-10 | Methode für behandlung von transplantaten vor transplantationen. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5135915A (de) |
EP (1) | EP0438526B1 (de) |
JP (1) | JPH04501264A (de) |
AT (1) | ATE111361T1 (de) |
CA (1) | CA1339092C (de) |
DE (1) | DE68918285T2 (de) |
WO (1) | WO1990003812A1 (de) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
US5824297A (en) * | 1990-06-25 | 1998-10-20 | Oncogene Science, Inc. | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
US5283058A (en) | 1990-08-30 | 1994-02-01 | The General Hospital Corporation | Methods for inhibiting rejection of transplanted tissue |
US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
US6399569B1 (en) * | 1991-03-11 | 2002-06-04 | Curis, Inc. | Morphogen treatments for limiting proliferation of epithelial cells |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6090776A (en) * | 1991-03-11 | 2000-07-18 | Creative Bio Molecules, Inc. | Morphogen treatment of organ implants |
US6194376B1 (en) | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
US5620971A (en) * | 1991-05-09 | 1997-04-15 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
US5723459A (en) * | 1991-05-09 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
ATE160486T1 (de) * | 1991-08-12 | 1997-12-15 | Nestle Sa | Nahrungsmittelzusammensetzung |
US5534026A (en) * | 1992-04-02 | 1996-07-09 | The Penn State Research Foundation | Preparation of inexpensive, HIV-free human skin allograft |
GB9210574D0 (en) * | 1992-05-18 | 1992-07-01 | Ca Nat Research Council | Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications |
WO1994028897A2 (en) * | 1993-06-07 | 1994-12-22 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
US5443824A (en) * | 1994-03-14 | 1995-08-22 | Piacquadio; Daniel J. | Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions |
US5976104A (en) * | 1994-08-19 | 1999-11-02 | Lifenet Research Foundation | Recirculation method for cleaning essentially intact bone grafts using pressure mediated flow of solutions and bone grafts produced thereby |
US5543423A (en) * | 1994-11-16 | 1996-08-06 | Vertex Pharmaceuticals, Incorporated | Amino acid derivatives with improved multi-drug resistance activity |
US5882328A (en) * | 1995-01-13 | 1999-03-16 | Qlt Phototherapeutics, Inc. | Method to prevent transplant rejection |
CA2249368A1 (en) | 1996-03-22 | 1997-09-25 | The General Hospital Corporation | Administration of polypeptide growth factors following central nervous system ischemia or trauma |
US6152142A (en) | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
TW586934B (en) * | 1997-05-19 | 2004-05-11 | Sumitomo Pharma | Immunopotentiating composition |
US7074762B2 (en) * | 1998-01-05 | 2006-07-11 | Washington University | Composition and method for improving function of embryonic kidney transplants |
US6364907B1 (en) | 1998-10-09 | 2002-04-02 | Qlt Inc. | Method to prevent xenograft transplant rejection |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
WO2001007568A2 (en) * | 1999-07-23 | 2001-02-01 | Diacrin, Inc. | Muscle cells and their use in cardiac repair |
US20030039659A1 (en) * | 1999-09-24 | 2003-02-27 | Mccormick Alison A. | Self antigen vaccines for treating B cell lymphomas and other cancers |
US7084256B2 (en) * | 1999-09-24 | 2006-08-01 | Large Scale Biology Corporation | Self antigen vaccines for treating B cell lymphomas and other cancers |
US20040208855A1 (en) * | 1999-11-17 | 2004-10-21 | Allison Beth Anne | Use of PDT to inhibit intimal hyperplasia |
AU5380201A (en) * | 2000-04-27 | 2001-11-07 | Ray Jui Fang Tsai | Method for expansion of epithelial stem cells |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US7485314B2 (en) * | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
US20050191309A1 (en) * | 2002-05-06 | 2005-09-01 | Kakkis Emil D. | Induction of antigen specific immunologic tolerance |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
WO2004037225A2 (en) | 2002-10-25 | 2004-05-06 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
JP2008540511A (ja) | 2005-05-09 | 2008-11-20 | フォーミックス エルティーディー. | 糖類発泡性組成物 |
GB0514262D0 (en) * | 2005-07-12 | 2005-08-17 | Renovo Ltd | Promotion of epithelial regeneration |
US8187639B2 (en) | 2005-09-27 | 2012-05-29 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
US8182841B2 (en) | 2005-09-27 | 2012-05-22 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-inflammation methods |
GB0604938D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Proteins, nucleic acids and medicaments |
GB0604966D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Medicaments and proteins |
GB0604964D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Protein folding |
GB0617816D0 (en) * | 2006-09-11 | 2006-10-18 | Renovo Ltd | Nucleic acids and methods of protein expression |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
EP2242476A2 (de) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
EP2717888B1 (de) | 2011-06-10 | 2020-09-09 | Tissuetech, Inc. | Verfahren zur verarbeitung fötaler gewebesubstrate |
US8716363B2 (en) * | 2011-09-28 | 2014-05-06 | Globus Medical, Inc. | Biodegradable putty compositions and implant devices, methods, and kits relating to the same |
JP6613412B2 (ja) * | 2014-04-03 | 2019-12-04 | 学校法人獨協学園獨協医科大学 | 移植免疫応答の抑制方法 |
TW201642914A (zh) | 2015-02-23 | 2016-12-16 | 組織科技股份有限公司 | 用於治療眼部疾病及失調的裝置及方法 |
TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3588058T3 (de) * | 1984-07-16 | 2005-04-07 | Celtrix Pharmaceuticals, Inc., Palo Alto | Knorpel-induzierende Polypeptid-Faktoren aus Knochen |
US4886786A (en) * | 1985-08-01 | 1989-12-12 | Lindstrom Richard L | Additive for irrigation solution or surgical solution |
US4806523A (en) * | 1985-08-06 | 1989-02-21 | Collagen Corporation | Method of treating inflammation |
NZ222168A (en) * | 1986-10-20 | 1991-05-28 | Oncogene Science Inc | Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions |
PT86144B (pt) * | 1986-11-17 | 1990-08-31 | Sandoz Sa | Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem |
EP0269408A3 (de) * | 1986-11-26 | 1989-08-30 | Genentech, Inc. | TGF-Beta für die Behandlung von entzündlichen Erkrankungen |
AU2844889A (en) * | 1988-01-22 | 1989-07-27 | Collagen Corporation | Method for suppressing the growth of normal and cancer cells |
US5055447A (en) * | 1988-07-28 | 1991-10-08 | Genentech, Inc. | Method and compositions for the treatment and prevention of septic shock |
-
1988
- 1988-10-14 US US07/258,276 patent/US5135915A/en not_active Expired - Lifetime
-
1989
- 1989-09-28 CA CA000613971A patent/CA1339092C/en not_active Expired - Lifetime
- 1989-10-10 WO PCT/US1989/004429 patent/WO1990003812A1/en active IP Right Grant
- 1989-10-10 EP EP89912606A patent/EP0438526B1/de not_active Expired - Lifetime
- 1989-10-10 AT AT89912606T patent/ATE111361T1/de not_active IP Right Cessation
- 1989-10-10 JP JP1511589A patent/JPH04501264A/ja active Pending
- 1989-10-10 DE DE68918285T patent/DE68918285T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1990003812A1 (en) | 1990-04-19 |
CA1339092C (en) | 1997-07-29 |
US5135915A (en) | 1992-08-04 |
DE68918285T2 (de) | 1995-03-02 |
EP0438526B1 (de) | 1994-09-14 |
JPH04501264A (ja) | 1992-03-05 |
ATE111361T1 (de) | 1994-09-15 |
EP0438526A1 (de) | 1991-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68918285T2 (de) | Methode für behandlung von transplantaten vor transplantationen. | |
ES2180653T3 (es) | Tratamiento de material biologico antes de la implantacion. | |
DE3855220T2 (de) | Methode zur beseitigung von infektionserregern in geweben | |
DE60026561D1 (de) | Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen | |
ATE177954T1 (de) | Verfahren zur behandlung von knochengeweben und implantierbare biomaterialien dafür | |
DE3587266D1 (de) | Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut. | |
DE60045034D1 (de) | Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen | |
ES8301616A1 (es) | Perfeccionamientos en los sistemas de protesis vascular. | |
NO982721D0 (no) | Preserverende oppl°sning | |
NO992569D0 (no) | FremgangsmÕter for Õ hindre podingsforkastelse i transplantasjon og for fremstilling av en universell genterapi vertcelle ved Õ anvende lymfocytt aktivering (LAG-3) | |
Tank | The ability of localized implants of whole or minced dermis to disrupt pattern formation in the regenerating forelimb of the axolotl | |
SE8800545D0 (sv) | Alster och forfarande for processkontroll | |
Kahanovich et al. | Increased resistance to infection of glutaraldehyde-treated human skin grafts | |
EP1728857A3 (de) | Bereitstellung von Lebergewebe. | |
RU2008767C1 (ru) | Способ консервирования биоткани для протезирования клапанов сердца и сосудов | |
SU1197656A1 (ru) | Способ сосудистой пластики | |
RU2033795C1 (ru) | Способ удаления костного мозга из аллотрансплантатов | |
BG101472A (en) | Vascular transplant and method for its preparation | |
RU96111020A (ru) | Способ усиления миграции и пролиферации и способ лечения | |
GB2156677A (en) | Bioprosthetic conduits | |
GR900100632A (en) | Skin treatment and method for the restoration of the skin against sun effects | |
RU94016342A (ru) | Способ лечения приживления при трансплантации кожных лоскутов в эксперименте | |
RU96111677A (ru) | Способ хирургического лечения хронической венозной недостаточности | |
RU93037867A (ru) | Способ лечения длительно незаживающих ран и трофических язв кожных покровов | |
RU94001977A (ru) | Способ хирургического лечения панкреатита |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |